raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:411629

Infantile nephropathic cystinosis

Type
Clinical subtype
Group
Subtype of disorder
Inheritance
Autosomal recessive
Age of onset
Infancy
Status
active

A subtype of cystinosis characterized by an accumulation of cystine in the organs and tissues, particularly in the kidneys and eyes, and that clinically manifests from infancy with renal Fanconi syndrome, photophobia, hypothyroidism, impaired growth and rickets, in addition to various other systemic effects. Progressive extra-renal manifestations include hypothyroidism, hypogonadism and male infertility, insulin-dependent diabetes, hepatosplenomegaly with portal hypertension, muscle involvement with distal muscle weakness and atrophy, pharyngeal and oral dysfunction, swallowing difficulties, cerebral involvement with hypotonia, speech and walking difficulties, and cerebellar syndrome.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enInfantile nephropathic cystinosis
frCystinose néphropathique infantile
deInfantile nephropathische Cystinose
esCistinosis nefropática infantil
itCistinosi nefropatica infantile
nlInfantiele nefropathische cystinose
ptCistinose nefropática da infância
plNiemowlęca cystynoza nefropatyczna
csInfantilní nefropatická cystinóza
ukІнфантильний нефропатичний цистиноз
zh肾病性婴儿胱氨酸贮积症
trNefropatik infantil sistinoz

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM219800NTBTvalidated
ICD-10E72.0+NTBTattributedvalidated
ICD-10N16.3*NTBTattributedvalidated
ICD-115C60.1NTBTindexvalidated
MONDO0018467Evalidated
MeSHC565655Evalidated
UMLSC3537440Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (3):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CTNSDisease-causing germline mutation(s) inAssessedHGNC:2518ENSG0000004053160627217p13.2cystinosin, lysosomal cystine transporter20301574[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyValidatedORPHANET
Prevalence at birth1-9 / 1 000 000—EuropeClass onlyValidated[EXPERT]_12110740[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

27 annotations · validated 2017-01-05
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0003111Abnormal blood ion concentration
HP:0100511Abnormality of vitamin D metabolism
HP:0001941Acidosis
HP:0003355Aminoaciduria
HP:0002019Constipation
HP:0000531Corneal crystals
HP:0001944Dehydration
HP:0001508Failure to thrive
HP:0003076Glycosuria
HP:0001510Growth delay
HP:0004918Hyperchloremic metabolic acidosis
HP:0003109Hyperphosphaturia
HP:0002900Hypokalemia
HP:0002148Hypophosphatemia
HP:0003126Low-molecular-weight proteinuria
HP:0000613Photophobia
HP:0001959Polydipsia
HP:0001994Renal Fanconi syndrome
HP:0000124Renal tubular dysfunction
HP:0002748Rickets
HP:0001969Tubulointerstitial abnormality
HP:0002013Vomiting
Frequent (79-30%)
HP:0000481Abnormal cornea morphology
HP:0002926Abnormality of thyroid physiology
HP:0000580Pigmentary retinopathy
Occasional (29-5%)
HP:0002500Abnormal cerebral white matter morphology
HP:0100543Cognitive impairment

Run the differential on the 12 obligate / very frequent terms

Annotation source: 25165189[PMID]_21980659[PMID]_18075494[PMID]

7

Sources for this card